Keyphrases
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
100%
RPh201
100%
Placebo
57%
Best-corrected Visual Acuity
57%
Adverse Effects
28%
Visual Evoked Potentials
14%
Twice Daily
14%
Visual Field
14%
Large Trials
14%
Safety Concerns
14%
Prospective Randomized Trial
14%
Randomized Placebo-controlled Trial
14%
Trial Registration
14%
Laboratory Values
14%
Retinal Nerve Fiber Layer
14%
Placebo Treatment
14%
Visual Structure
14%
Vital Signs
14%
Clinically Significant Change
14%
Visual Function
14%
Injection Pain
14%
Early Treatment Diabetic Retinopathy Study
14%
Cottonseed Oil
14%
Sign Value
14%
Medicine and Dentistry
Placebo
100%
Arteritic Anterior Ischemic Optic Neuropathy
100%
Best Corrected Visual Acuity
66%
Adverse Effect
33%
Visual Evoked Potential
16%
Population Research
16%
Visual Field
16%
Post-Hoc Analysis
16%
Retinal Nerve Fiber Layer
16%
Vital Sign
16%
Diabetic Retinopathy
16%
Injection Site Pain
16%
Neuroscience
Placebo
100%
Optic Neuropathy
100%
Adverse Effect
33%
Visual Evoked Potential
16%
Nerve Fiber
16%
Diabetic Retinopathy
16%
Cotton Seed Oil
16%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Anterior Ischemic Optic Neuropathy
100%
Population Study
16%
Diabetic Retinopathy
16%
Injection Site Pain
16%
Cotton Seed Oil
16%